Skip to Content

Xylem Inc

XYL: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$334.00MdghnTdfxblml

Xylem Earnings: Healthy Demand and Supply Chain Improvement Drive Strong Revenue Growth

Narrow-moat-rated Xylem reported strong first-quarter results, featuring a 53% year-over-year increase in adjusted EPS, from $0.47 to $0.72, driven by robust demand across all segments as well as improvement in chip supply. We’ve increased our fair value estimate to $97 from $95, which reflects our slightly more optimistic near-term revenue growth projections as well as time value of money.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of XYL so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center